AU2022903363A0 - Treatment methods for inherited retinal diseases - Google Patents

Treatment methods for inherited retinal diseases

Info

Publication number
AU2022903363A0
AU2022903363A0 AU2022903363A AU2022903363A AU2022903363A0 AU 2022903363 A0 AU2022903363 A0 AU 2022903363A0 AU 2022903363 A AU2022903363 A AU 2022903363A AU 2022903363 A AU2022903363 A AU 2022903363A AU 2022903363 A0 AU2022903363 A0 AU 2022903363A0
Authority
AU
Australia
Prior art keywords
treatment methods
retinal diseases
inherited retinal
inherited
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022903363A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Research Institute
Original Assignee
Childrens Medical Research Institute
Filing date
Publication date
Application filed by Childrens Medical Research Institute filed Critical Childrens Medical Research Institute
Publication of AU2022903363A0 publication Critical patent/AU2022903363A0/en
Pending legal-status Critical Current

Links

AU2022903363A 2022-11-10 Treatment methods for inherited retinal diseases Pending AU2022903363A0 (en)

Publications (1)

Publication Number Publication Date
AU2022903363A0 true AU2022903363A0 (en) 2022-11-24

Family

ID=

Similar Documents

Publication Publication Date Title
EP3986392A4 (en) Compounds for treatment of pd-l1 diseases
IL287802A (en) Compositions and methods for treatment of ocular diseases
EP4100406A4 (en) Compositions for treatment of ocular diseases
IL289405A (en) Personalized treatment of ophthalmologic diseases
EP4267196A4 (en) Treatment of neurological diseases
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3938364A4 (en) Compounds for and methods of treating diseases
EP4175944A4 (en) Peptides for treatment of medical disorders
EP3952859A4 (en) Methods for treatment of niemann-pick disease type c
AU2022296903A1 (en) Treatment for autoimmune diseases
AU2023903475A0 (en) Treatment methods for inherited retinal diseases
AU2022903363A0 (en) Treatment methods for inherited retinal diseases
AU2021903570A0 (en) Treatment methods for inherited retinal diseases
IL289436A (en) Methods for treating ocular diseases
EP3787749A4 (en) Methods of treating retinal diseases
EP4143202A4 (en) Method of treating ship1-mediated diseases using pelorol derivatives
SG11202110659SA (en) Method for treating ocular diseases
EP3823603A4 (en) Ophthalmic compositions and methods for the treatment of eye disorders and skin diseases
AU2024900640A0 (en) Treatment methods for muscle-associated diseases
AU2021903441A0 (en) Methods for treating respiratory diseases
AU2021902437A0 (en) Compositions and methods for treatment of an inherited retinal disease
EP4138820A4 (en) Small molecules for treating age-related retinal diseases
AU2021901964A0 (en) New treatment for neurodegenerative diseases
AU2020902218A0 (en) New treatment for neurodegenerative diseases